A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19
Rossignol et al., eClinicalMedicine, doi:10.1016/j.eclinm.2022.101310 (preprint 4/20/2021)
https://c19early.org/rossignol.html